PainReform Ltd. (NASDAQ:PRFX – Get Free Report) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 63,000 shares, an increase of 85.3% from the February 13th total of 34,000 shares. Currently, 7.4% of the shares of the stock are sold short. Based on an average trading volume of 3,210,000 shares, the short-interest ratio is presently 0.0 days.
PainReform Price Performance
Shares of NASDAQ PRFX traded up $0.14 during mid-day trading on Friday, reaching $2.79. 73,408 shares of the company traded hands, compared to its average volume of 1,102,021. PainReform has a fifty-two week low of $1.73 and a fifty-two week high of $61.20. The firm has a market cap of $2.44 million, a PE ratio of -0.02 and a beta of 0.61. The stock has a fifty day simple moving average of $3.10 and a 200-day simple moving average of $2.95.
Hedge Funds Weigh In On PainReform
An institutional investor recently bought a new position in PainReform stock. Apollon Wealth Management LLC bought a new position in shares of PainReform Ltd. (NASDAQ:PRFX – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 12,917 shares of the company’s stock, valued at approximately $43,000. Apollon Wealth Management LLC owned 9.23% of PainReform as of its most recent SEC filing. Hedge funds and other institutional investors own 37.28% of the company’s stock.
About PainReform
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.
Read More
- Five stocks we like better than PainReform
- What Are the U.K. Market Holidays? How to Invest and Trade
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Invest in Insurance Companies: A Guide
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for PainReform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainReform and related companies with MarketBeat.com's FREE daily email newsletter.
